This is the last age group that cannot yet be vaccinated.
The European Medicines Agency (EMA) announced on Thursday that it has started the review of Moderna's messenger RNA vaccine against Covid-19 in children between 6 months and 5 years old.
"We have just begun the evaluation of an application from Moderna to expand the use of Spikevax (the name of Moderna's vaccine) to children six months to five years of age, and this is the first application for this young group of children. 'age," Marco Cavaleri, EMA's head of vaccine strategy, told a news conference.
EMA Press Briefing on COVID-19 related activities, 5 May 2022 https://t.co/8L49WmTY1o
— EU Medicines Agency (@EMA_News) May 5, 2022
American biotech company Moderna already made a similar request in the United States last week after trials showed its injections were safe and produced a strong immune response.
Read alsoWhy are children so little vaccinated against Covid-19 in France?
Young children are less vulnerable to the virus than older people, but they can still get sick and transmit the virus.
They can also contract severe cases of pediatric multisystem inflammatory syndrome (MIS-C).
Not recommended for people under 30
In February, the EMA approved the use of Moderna's Covid vaccine for children aged six and over in the 27 countries of the European Union.
On November 8, in France, the High Authority for Health advised against this vaccine for people under 30, based on an EMA opinion on the Epi-Phare report confirming the risk of myocarditis and pericarditis, recommends dispensing with the Moderna vaccine in young people.
